AI Insight
Researchers from Mass General Brigham Heart and Vascular Institute found that a single intravenous iron infusion significantly improved exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF) who had iron deficiency. The study, presented at the 2026 American Heart Association Scientific Sessions and published in Circulation, demonstrates that correcting iron deficiency may help alleviate physical limitations in this patient population. HFpEF is the most common form of heart failure, accounting for approximately half of all heart failure cases.
Why it matters
This finding offers a relatively simple and potentially cost-effective intervention for improving quality of life in HFpEF patients, a condition that currently has limited treatment options. If validated in larger trials, iron supplementation could become a standard component of care for iron-deficient heart failure patients, potentially reducing disability and hospitalizations.
Understand the Science
A new study by investigators from the Mass General Brigham Heart and Vascular Institute found that a single iron infusion improved exercise capacity in people with heart failure with preserved ejection fraction (HFpEF) and iron deficiency. The findings suggest that replenishing iron could help address the physical limitations associated with this condition. Results were presented at the 2026 American Heart Association Scientific Sessions and published simultaneously in Circulation.
Source: Single iron infusion improved exercise capacity in people with the most common form of heart failure